Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis
InfectologiaSobre o estudo
- Desenho
- Metanálise
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
- Publicado em
- 2 mar 2022
- Citações
- 0
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis
Mohammad Javad Nasiri, Moein Zangiabadian, Erfan Arabpour, Sirus Amini, Farima Khalili, Rosella Centis, Lia D'Ambrosio, Justin T Denholm, H Simon Schaaf, Martin van den Boom et al.
Descritores MeSH
- Tuberculosis, Multidrug-Resistant
- Nitroimidazoles
- Antitubercular Agents
- Treatment Outcome
- Diarylquinolines
- Oxazoles
- Humans
Veja também
Estudos relacionados
- Hepatic Safety of Bedaquiline, Delamanid, and Pretomanid: A Systematic Review and Meta-analysis
- Efficacy and safety of bedaquiline and delamanid in the treatment of drug-resistant tuberculosis in adults: A systematic review and meta-analysis
- Efficacy and Tolerability of Concomitant Use of Bedaquiline and Delamanid for Multidrug- and Extensively Drug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis
- Favorable outcome of individual regimens containing bedaquiline and delamanid in drug-resistant tuberculosis: A systematic review